BioXpedia A/S

At the moment, BioXpedia is offering a 40% discount on our Cardiometabolic Olink® analysis panel to support groundbreaking research on cardiovascular and metabolic diseases. Don’t miss this opportunity to advance patient care! #BioXpedia #CardiometabolicHealth #OlinkProteomics #HeartResearch #ValentinesDay #HealthcareInnovation

Advancing Cardiometabolic Research with BioXpedia – Special Valentine's Offer ❤️ At BioXpedia, we are committed to supporting researchers and clinicians in the fight against cardiometabolic diseases. This Valentine’s Day, we’re offering an exclusive 40% discount on our Cardiometabolic Olink® panel analyses, screening for 369 biomarkers linked to cardiovascular and metabolic disease. Why choose BioXpedia’s advanced proteomics solutions? ✔ Comprehensive screening – Gain insights into 369 key cardiometabolic biomarkers ✔ Precision proteomics – High-throughput, data-driven solutions for cutting-edge research ✔ Accelerated discoveries – Identify novel pathways and improve patient outcomes We show heart patients extra love this Valentine’s Day by supporting the research that leads to better diagnostics, treatments, and care. Limited availability – Contact us to learn more: https://lnkd.in/dc4D2mwB info@BioXpedia.com #BioXpedia #CardiometabolicHealth #PrecisionMedicine #OlinkProteomics #HeartResearch #ValentinesDay #HealthcareInnovation

BioXpedia Analysis Service: Olink Reveal – New panel - More affordable The next evolution in proteomics is here! Olink Reveal is a targeted, cost-effective proteomics panel designed to maximize biological insights while lowering barriers to large-scale studies. With ~1,000 carefully selected proteins, Reveal captures key pathways identified in the UK Biobank study and other high-impact research. This means researchers get deep biological insights into inflammation, disease mechanisms, and therapeutic targets - at a fraction of the cost of larger panels. 🔬 Why Olink Reveal matters? ✅ Focused on highly relevant proteins, ensuring meaningful discoveries ✅ Backed by UK Biobank findings, enabling precision biomarker research ✅ More affordable than larger proteomics panels, making high-quality data accessible to more studies By bridging cutting-edge proteogenomics with affordability, Olink Reveal empowers researchers to drive breakthroughs in precision medicine, drug discovery, and beyond. Contact us for more information and prices for analysis service: info@bioxpedia.com and www.bioxpedia.com   #Proteomics #OlinkReveal #PrecisionMedicine #Biomarkers #DrugDiscovery #UKBiobank  

World’s Largest Proteome Study is leveraging Olink Technology. The UK Biobank Pharma Proteomics Project will analyse over 600,000 samples to map disease-associated protein levels and advance biomarker discovery. The study is a collaboration between UK Biobank and 14 leading biopharmaceutical companies. It comes as no surprise that Olink has been chosen for this monumental study, as Olink stands as the undisputed world leader in the affinity proteomics field. With over 19,000 researchers worldwide already using UK Biobank data, this initiative is poised to have a major impact. Massive proteomics studies such as the UK Biobank Pharma Proteomics Project are transforming our understanding of health and disease by revealing how proteins influence biological processes. These efforts are paving the way for earlier diagnoses, better treatments, and precision medicine — helping to improve lives and reduce the burden of disease worldwide. Explore how our Olink services can accelerate your research: www.bioxpedia.com #Proteomics #ClinicalResearch #PrecisionMedicine #LifeSciences #DrugDevelopment

Targeting Disease with Precision: siRNA to the Rescue New drug candidates don’t just appear—they are discovered through rigorous testing and innovation. At BioXpedia A/S, we are proud to offer a comprehensive approach to siRNA and antisense oligo (ASO) screening. We test siRNA and ASOs in both in vitro (cell-based) and in vivo (rodent) models. This dual-platform capability enables us to support your drug discovery pipeline at multiple stages, providing insights into molecular interactions and therapeutic potential. Whether you are screening molecular libraries or narrowing down your list of candidates, we are here to help you knock out the competition—disease by disease, target by target. Ready to take your research further? Let’s connect at www.bioXpedia.com #TranslationalResearch #Neuroscience #DrugDiscovery #Genetics

Olink Proteomics Fast Track! Are your samples ready? Do you have funding in place? Turnaround time: as fast as three weeks. Choose from: • Olink Target 48 • Olink Target 96 • Olink Explore 384 • Olink Explore 3072 • Olink Explore HT 📧 Contact us at info@bioxpedia.com 🌐 Visit www.bioxpedia.com Let us help you fast-track your proteomics project! #ClinicalResearch #Drugdiscovery #Drugdevelopment #LifeScience #Precisionmedicine

Olink Proteomics Fast Track! Are your samples ready? Do you have funding in place? Turnaround time: as fast as three weeks. Choose from: • Olink Target 48 • Olink Target 96 • Olink Explore 384 • Olink Explore 3072 • Olink Explore HT 📧 Contact us at info@bioxpedia.com 🌐 Visit www.bioxpedia.com Let us help you fast-track your proteomics project! #ClinicalResearch #Drugdiscovery #Drugdevelopment #LifeScience #Precisionmedicine

Olink Proteomics Fast Track! Are your samples ready? Do you have funding in place? Turnaround time: as fast as three weeks. Choose from: • Olink Target 48 • Olink Target 96 • Olink Explore 384 • Olink Explore 3072 • Olink Explore HT 📧 Contact us at info@bioxpedia.com 🌐 Visit www.bioxpedia.com Let us help you fast-track your proteomics project! #ClinicalResearch #Drugdiscovery #Drugdevelopment #LifeScience #Precisionmedicine

Olink Fast Track! Are your samples ready? Do you have funding in place? Turnaround time: as fast as three weeks. Choose from: • Olink Target 48 • Olink Target 96 • Olink Explore 384 • Olink Explore 3072 • Olink Explore HT 📧 Contact us at info@bioxpedia.com 🌐 Visit www.bioxpedia.com Let us help you fast-track your proteomics project!

Last Call for Lunch Registration: Biomarkers in Cardiometabolic Research Secure your spot today and join us for a lunch seminar and networking event at Steno Diabetes Center Aarhus, in collaboration with Olink Proteomics. Friday is the last day to register for lunch! Explore research revealing how elevated proglucagon and genetic variations predict the onset of type 2 diabetes, and gain new insight into the impact of low birth weight and childhood obesity on cardiometabolic health. 📅: Tuesday, 29th October ⌛: 11:00 – 12:05 🍔: Lunch & networking 12:05 -13:00 📍: Auditorium "Verdensrummet", Steno Diabetes Center Aarhus Don’t miss the opportunity to network over lunch with researchers passionate about biomarkers and cardiometabolic health. Register here: https://lnkd.in/giUdmJVb #biomarkers #olink #diabetes #proteomics #lifescience